News for Healthier Living

A Way to 'Unstick' Cancer's Glue? How Experimental Drug FL118 Disrupts Tumor Survival Networks

Writing in the Journal of Experimental & Clinical Cancer Research, scientists from Roswell Park report that the investigational anticancer agent FL118 functions as a dual molecular glue degrader that directly targets and degrades two emerging therapeutic targets.

August 7, 2026


August 7 2026

August 6 2026

August 5 2026

August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026